Lontax Plus Fidia 20ml

Lontax Plus Fidia - Nasal Spray Medical Device

With protective barrier activity against cold viruses A Based on Carragelose® and kappa-carrageenan for the supportive treatment of flu-like syndromes.

Lontax Plus based on Carragelose®, a polymer extracted from red algae that creates a protective physical barrier on the nasal mucosa, reducing the spread and proliferation of cold viruses, including Rhinovirus and Coronavirus.
Nonspecific virus trapping activity was also shown in in vitro tests for SARS-CoV-2.
While it cannot completely avoid a SARS-CoV-2 infection, it can still significantly reduce the risk of infection and spread of the virus.

Composition

1 ml of solution contains 1.2 mg of iota-carrageenan (Carragelose®), 0.4 mg of kappa-carrageenan, sodium chloride and purified water.

Dosage

Spray at least 3 times a day for each nostril

Antiviral efficacy

Reduction of viral load 1-6
Effective against various viruses (Rhinovirus, Coronavirus, Adenovirus, RSV, Influenza, etc.) 1-6

Benefits for patients

Mitigates severity and reduces cold and flu symptoms
Reduces the onset of new infections and flare-ups of viral cold symptoms

Safety

Absence of adverse events demonstrated in clinical studies 3-5
There is no risk of addiction or overdose
Does not alter the permeability of the nasal mucosa 7-9
It can be used in adults, in children from 1 year of age, during pregnancy and lactation, in diabetic patients
Free of lactose and gluten

Format

20ml spray bottle.